Literature DB >> 17213723

Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.

J C Gómez-Esteban1, J J Zarranz, E Lezcano, B Tijero, A Luna, F Velasco, I Rouco, I Garamendi.   

Abstract

We studied the impact of various motor and nonmotor symptoms upon quality of life in patients with Parkinson's disease (PD). The study comprised 110 patients with PD (age: 68.6 years, course of the disease: 7.6 years). The Unified Parkinson Disease Rating Scale (UPDRS; I-IV) and Parkinson's Disease Questionnaire (PDQ-39) were recorded. We recorded the correlations between years of disease and UPDRS IV, as well as PDQ-39 and UPDRS I, II, III and IV. Introduction of all variables into a linear regression model showed that 3 variables accounted for 51% of the variance in PDQ-39. Mental condition, gait disorders and complications of dopaminergic drugs are the variables that most affect the quality of life of patients with PD. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17213723     DOI: 10.1159/000098468

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  38 in total

1.  Concordance between severity of disease, prevalence of nonmotor symptoms, patient-reported quality of life and disability and use of medication in Parkinson's disease.

Authors:  Alberto Raggi; Matilde Leonardi; Venusia Covelli; Alberto Albanese; Paola Soliveri; Francesco Carella; Luigi Romito
Journal:  Neurol Sci       Date:  2011-11-10       Impact factor: 3.307

2.  Energy cost of spontaneous walking in Parkinson's disease patients.

Authors:  Martina A Maggioni; Arsenio Veicsteinas; Susanna Rampichini; Emiliano Cè; Raffaello Nemni; Giulio Riboldazzi; Giampiero Merati
Journal:  Neurol Sci       Date:  2011-11-01       Impact factor: 3.307

3.  Pseudobulbar affect: prevalence and quality of life impact in movement disorders.

Authors:  Roy E Strowd; Michael S Cartwright; Michael S Okun; Ihtsham Haq; Mustafa S Siddiqui
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

4.  Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.

Authors:  Cicely Kerr; Emily J Lloyd; Charlotte E Kosmas; Helen T Smith; James A Cooper; Karissa Johnston; Emma McIntosh; Andrew J Lloyd
Journal:  Qual Life Res       Date:  2015-12-01       Impact factor: 4.147

5.  Health-related quality of life of australians with Parkinson disease: a comparison with international studies.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Meg E Morris
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

Review 6.  Classification of gait disturbances: distinguishing between continuous and episodic changes.

Authors:  Nir Giladi; Fay B Horak; Jeffrey M Hausdorff
Journal:  Mov Disord       Date:  2013-09-15       Impact factor: 10.338

7.  Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease?

Authors:  T Ellis; J T Cavanaugh; G M Earhart; M P Ford; K B Foreman; L E Dibble
Journal:  Parkinsonism Relat Disord       Date:  2011-08-05       Impact factor: 4.891

8.  Italian validation of the Belastungsfragebogen Parkinson kurzversion (BELA-P-k): a disease-specific questionnaire for evaluation of the subjective perception of quality of life in parkinson's disease.

Authors:  Paola Ortelli; Roberto Maestri; Marianna Zarucchi; Veronica Cian; Elisa Urso; Francesca Giacomello; Davide Ferrazzoli; Giuseppe Frazzitta
Journal:  J Clin Mov Disord       Date:  2017-07-25

9.  Determinants of health-related quality of life in people with Parkinson's disease: a path analysis.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Anna T Murphy; Hylton B Menz; Frances Huxham; Meg E Morris
Journal:  Qual Life Res       Date:  2012-10-16       Impact factor: 4.147

10.  Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Kai Bötzel; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.